Kezar Life Sciences, Inc. (Nasdaq:KZR)

Health Care/Life Sciences • Biotechnology

CIK 1645666

Company

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.

Address
4000 Shoreline Court
Suite 300
South San Francisco, California 94080

Employees
84

Stock Info

Close
$1.0300

Day Range
0.9800 - 1.0600

52 Week Range
0.6746 - 5.7900

Average volume
740.56K

Short Interest
3M (02/15/24)

% of Float Shorted
4.85%

Market Cap
$74.26M

Revenue
N/A

Net Income
-$68.24M

2020 Sales Growth
N/A

Rev. per Employee
$83.33K

P/E Ratio
N/A

EPS
-$1.2120

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Chief Executive Officer & Director
Christopher J Kirk PhD

Director
John Fowler MBA

Chairman
Graham K Cooper MBA, CPA

Independent Director
Micki Klearman MD

Independent Director
Elizabeth Ijeoma Onyemelukwe Garner MD

Independent Director
Courtney Wallace MBA

Director
Franklin M Berger CFA, MBA

Independent Director
Michael G Kauffman MD, PhD

SEC filings

Date	Form	Event
3 Dec, 2024	8-K
14 Nov, 2024	8-K
14 Nov, 2024	SCHEDULE 1
12 Nov, 2024	8-K
12 Nov, 2024	10-Q
29 Oct, 2024	8-A12B/A
28 Oct, 2024	8-K
17 Oct, 2024	8-A12B
17 Oct, 2024	8-K
10 Oct, 2024	8-K
8 Oct, 2024	SC 13D
4 Oct, 2024	8-K
30 Sep, 2024	8-K
13 Aug, 2024	8-K
13 Aug, 2024	10-Q
26 Jul, 2024	4
8 Jul, 2024	SC 13G/A
21 Jun, 2024	4
21 Jun, 2024	8-K
21 Jun, 2024	4
21 Jun, 2024	4
21 Jun, 2024	4
21 Jun, 2024	4
21 Jun, 2024	4
4 Jun, 2024	8-K
9 May, 2024	8-K
9 May, 2024	10-Q
26 Apr, 2024	DEFA14A
26 Apr, 2024	DEF 14A
26 Apr, 2024	ARS
16 Apr, 2024	PRE 14A
22 Mar, 2024	424B5
14 Mar, 2024	8-K
14 Mar, 2024	S-8
14 Mar, 2024	10-K
14 Feb, 2024	SC 13G
14 Feb, 2024	SC 13G/A
14 Feb, 2024	SC 13G/A
13 Feb, 2024	SC 13G/A
13 Feb, 2024	SC 13G/A
29 Jan, 2024	SC 13G/A
23 Jan, 2024	SC 13G/A
22 Jan, 2024	SC 13G/A
17 Jan, 2024	3
9 Jan, 2024	4
9 Jan, 2024	4
8 Jan, 2024	8-K
4 Dec, 2023	8-K
13 Nov, 2023	10-Q
13 Nov, 2023	8-K
9 Nov, 2023	4
27 Oct, 2023	8-K
3 Oct, 2023	8-K	CEO Change
21 Sep, 2023	8-K
17 Aug, 2023	SC 13D/A
17 Aug, 2023	4
14 Aug, 2023	8-K
10 Aug, 2023	10-Q
10 Aug, 2023	8-K
26 Jul, 2023	4
26 Jul, 2023	8-K
26 Jul, 2023	4
26 Jul, 2023	4
26 Jul, 2023	4
26 Jul, 2023	4
26 Jul, 2023	4
26 Jul, 2023	4
26 Jul, 2023	4
26 Jul, 2023	4
26 Jul, 2023	4
26 Jul, 2023	4
24 Jul, 2023	4
21 Jun, 2023	SC 13G
16 Jun, 2023	8-K
16 Jun, 2023	4
16 Jun, 2023	4
16 Jun, 2023	4
16 Jun, 2023	4
16 Jun, 2023	4
16 Jun, 2023	4
11 May, 2023	8-K
11 May, 2023	10-Q
11 May, 2023	S-8
5 May, 2023	EFFECT
27 Apr, 2023	8-K
27 Apr, 2023	DEF 14A
27 Apr, 2023	DEFA14A
21 Apr, 2023	SC 13G
17 Apr, 2023	PRE 14A
14 Mar, 2023	POSASR
14 Mar, 2023	10-K
14 Mar, 2023	POS AM
14 Mar, 2023	8-K
28 Feb, 2023	8-K
14 Feb, 2023	SC 13G/A
14 Feb, 2023	SC 13G/A
14 Feb, 2023	SC 13G
13 Feb, 2023	SC 13G/A
7 Feb, 2023	4
3 Feb, 2023	SC 13G
3 Feb, 2023	SC 13G
3 Feb, 2023	4
1 Feb, 2023	4
31 Jan, 2023	SC 13G/A
27 Jan, 2023	4
25 Jan, 2023	4
19 Jan, 2023	4
17 Jan, 2023	SC 13G/A
17 Jan, 2023	4
11 Jan, 2023	5
10 Jan, 2023	4
10 Jan, 2023	4
10 Jan, 2023	4
10 Jan, 2023	4
10 Jan, 2023	4
9 Jan, 2023	4
9 Jan, 2023	8-K
5 Jan, 2023	4
14 Nov, 2022	4
10 Nov, 2022	8-K
10 Nov, 2022	10-Q
3 Nov, 2022	8-K
5 Oct, 2022	4
11 Aug, 2022	10-Q
11 Aug, 2022	8-K
2 Aug, 2022	4
15 Jul, 2022	3
11 Jul, 2022	8-K
27 Jun, 2022	4
27 Jun, 2022	8-K
23 Jun, 2022	SC 13G
17 Jun, 2022	4
17 Jun, 2022	4
17 Jun, 2022	4
17 Jun, 2022	4
17 Jun, 2022	4
17 Jun, 2022	4
16 Jun, 2022	8-K
13 Jun, 2022	SC 13G
13 May, 2022	8-K
13 May, 2022	4
12 May, 2022	8-K
12 May, 2022	10-Q
9 May, 2022	SC 13G
3 May, 2022	8-K
26 Apr, 2022	DEF 14A
26 Apr, 2022	DEFA14A
22 Mar, 2022	4
17 Mar, 2022	10-K
17 Mar, 2022	S-8
17 Mar, 2022	8-K
14 Feb, 2022	SC 13G/A
11 Feb, 2022	SC 13G/A
4 Feb, 2022	SC 13G
3 Feb, 2022	SC 13G/A
7 Jan, 2022	4
7 Jan, 2022	8-K
7 Jan, 2022	4
7 Jan, 2022	4
7 Jan, 2022	4
5 Jan, 2022	4
3 Jan, 2022	SC 13G
20 Dec, 2021	8-K
20 Dec, 2021	S-3ASR
15 Dec, 2021	4
10 Dec, 2021	4
10 Dec, 2021	3
10 Dec, 2021	8-K
19 Nov, 2021	8-K
19 Nov, 2021	424B5
15 Nov, 2021	8-K
9 Nov, 2021	8-K
9 Nov, 2021	10-Q
23 Sep, 2021	4
12 Aug, 2021	8-K
12 Aug, 2021	10-Q
29 Jul, 2021	SC 13G
30 Jun, 2021	4
30 Jun, 2021	8-K
30 Jun, 2021	4
30 Jun, 2021	4
30 Jun, 2021	4
30 Jun, 2021	4
30 Jun, 2021	4
30 Jun, 2021	4
3 Jun, 2021	4
3 Jun, 2021	3
2 Jun, 2021	8-K
2 Jun, 2021	DEFA14A
1 Jun, 2021	8-K
12 May, 2021	8-K
12 May, 2021	10-Q
29 Apr, 2021	DEFA14A
29 Apr, 2021	DEF 14A
29 Mar, 2021	4
11 Mar, 2021	S-8
11 Mar, 2021	8-K
11 Mar, 2021	10-K
16 Feb, 2021	SC 13D/A
12 Feb, 2021	SC 13G/A
12 Feb, 2021	SC 13G/A
8 Feb, 2021	SC 13G/A
2 Feb, 2021	SC 13G
11 Jan, 2021	8-K
11 Jan, 2021	4
11 Jan, 2021	4
11 Jan, 2021	4
11 Jan, 2021	4
11 Jan, 2021	4
4 Jan, 2021	4

Last update:2024-03-06 12:15:50.599129

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.